Kurt P. Rindoks - Aug 26, 2022 Form 4 Insider Report for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)

Role
VP - Global Prod Development
Signature
/s/ Donald T. Gardner III, Attorney-in-fact
Stock symbol
KEQU
Transactions as of
Aug 26, 2022
Transactions value $
$17
Form type
4
Date filed
8/29/2022, 02:35 PM
Previous filing
Jul 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KEQU Common Stock Options Exercise $50.9K +3K +20.62% $16.97 17.5K Aug 26, 2022 Direct F1
transaction KEQU Common Stock Tax liability -$50.9K -2.56K -14.59% $19.88 15K Aug 26, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KEQU Option to Buy FY16 Options Exercise $0 -3K -100% $0.00* 0 Aug 26, 2022 Common Stock 3K $16.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon exercise as reported below on this Form 4 report.
F2 Employee stock option granted under Employee Stock Option plan under Rule 16b-3.